| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-556
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-552
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-67
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2003-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_245861506cce3169360d4256dd200663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b960991e358e407a75d4d121f0c5f28a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca4c69c010162a86e14662e9c93eee56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a3e8ae139f0ad578e3cb385bc178832
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8c3fbd83a1914de1c13e57168b61ef6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d97db849c6f2be907289ecd6f2328392
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53541d814f9a3ff6825d0d2b99603c33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14945b9ea205434d75a87816ed7299bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3773183b72519e4ff5667d80a6c37d27 |
| publicationDate |
2004-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004005641-A1 |
| titleOfInvention |
Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| abstract |
This invention features a method of identifying a compound useful for enhancing efficacy of a therapeutic agent. The method includes incubating a compound in blood cells; separating immune cells from erythrocytic cells; and determining the ratio of the concentration of the compound in the immune cells to the concentration of the compound in the erythrocytic cells; wherein the compound comprises a transportophore and a therapeutic agent, in which the transportophore is covalently bonded to the therapeutic agent via a bond or a linker. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004077612-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004097434-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005080003-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8357506-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7109176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7157433-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7579334-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004014685-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009221697-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7091187-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005129619-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009093014-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9050378-B2 |
| priorityDate |
2002-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |